BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 31549316)

  • 1. WiNTRLINC1/ASCL2/c-Myc Axis Characteristics of Colon Cancer with Differentiated Histology at Young Onset and Essential for Cell Viability.
    Yokota K; Tanaka Y; Harada H; Kaida T; Nakamoto S; Soeno T; Fujiyama Y; Yokota M; Kojo K; Miura H; Yamanashi T; Sato T; Nakamura T; Watanabe M; Yamashita K
    Ann Surg Oncol; 2019 Dec; 26(13):4826-4834. PubMed ID: 31549316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascl2 knockdown results in tumor growth arrest by miRNA-302b-related inhibition of colon cancer progenitor cells.
    Zhu R; Yang Y; Tian Y; Bai J; Zhang X; Li X; Peng Z; He Y; Chen L; Pan Q; Fang D; Chen W; Qian C; Bian X; Wang R
    PLoS One; 2012; 7(2):e32170. PubMed ID: 22384170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism.
    Christensen LL; True K; Hamilton MP; Nielsen MM; Damas ND; Damgaard CK; Ongen H; Dermitzakis E; Bramsen JB; Pedersen JS; Lund AH; Vang S; Stribolt K; Madsen MR; Laurberg S; McGuire SE; Ørntoft TF; Andersen CL
    Mol Oncol; 2016 Oct; 10(8):1266-82. PubMed ID: 27396952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achaete-scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression.
    Kato Y; Fukazawa T; Tanimoto K; Kanawa M; Kojima M; Saeki I; Kurihara S; Touge R; Hirohashi N; Okada S; Hiyama E
    Cancer Sci; 2024 Mar; 115(3):847-858. PubMed ID: 38183173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.
    Ling H; Spizzo R; Atlasi Y; Nicoloso M; Shimizu M; Redis RS; Nishida N; Gafà R; Song J; Guo Z; Ivan C; Barbarotto E; De Vries I; Zhang X; Ferracin M; Churchman M; van Galen JF; Beverloo BH; Shariati M; Haderk F; Estecio MR; Garcia-Manero G; Patijn GA; Gotley DC; Bhardwaj V; Shureiqi I; Sen S; Multani AS; Welsh J; Yamamoto K; Taniguchi I; Song MA; Gallinger S; Casey G; Thibodeau SN; Le Marchand L; Tiirikainen M; Mani SA; Zhang W; Davuluri RV; Mimori K; Mori M; Sieuwerts AM; Martens JW; Tomlinson I; Negrini M; Berindan-Neagoe I; Foekens JA; Hamilton SR; Lanza G; Kopetz S; Fodde R; Calin GA
    Genome Res; 2013 Sep; 23(9):1446-61. PubMed ID: 23796952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Nuclear Receptor Subfamily 1 Group H Member 4 (NR1H4) in Colon Cancer Cell Survival through the Regulation of c-Myc Stability.
    Lee YJ; Lee EY; Choi BH; Jang H; Myung JK; You HJ
    Mol Cells; 2020 May; 43(5):459-468. PubMed ID: 32299194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal regulation of lncRNA MEF and c-Myc drives colorectal cancer tumorigenesis.
    Wu S; Dai X; Zhu Z; Fan D; Jiang S; Dong Y; Chen B; Xie Q; Yao Z; Li Q; Thorne RF; Lu Y; Gu H; Hu W
    Neoplasia; 2024 Mar; 49():100971. PubMed ID: 38301392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of IAP family proteins in colon cancers from patients with different age groups.
    Endo T; Abe S; Seidlar HB; Nagaoka S; Takemura T; Utsuyama M; Kitagawa M; Hirokawa K
    Cancer Immunol Immunother; 2004 Sep; 53(9):770-6. PubMed ID: 15138717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intricate crosstalk between MYC and non-coding RNAs regulates hallmarks of cancer.
    Swier LJYM; Dzikiewicz-Krawczyk A; Winkle M; van den Berg A; Kluiver J
    Mol Oncol; 2019 Jan; 13(1):26-45. PubMed ID: 30451365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer.
    Shigeyasu K; Toden S; Ozawa T; Matsuyama T; Nagasaka T; Ishikawa T; Sahoo D; Ghosh P; Uetake H; Fujiwara T; Goel A
    Mol Cancer; 2020 Nov; 19(1):155. PubMed ID: 33148262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcorynoline Induces Apoptosis and G2/M Phase Arrest through the c-Myc Signaling Pathway in Colon Cancer Cells.
    Park YR; Jee W; Park SM; Kim SW; Jung JH; Kim H; Kim KI; Jang HJ
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASCL2 is a key regulator of the proliferation-differentiation equilibrium in the esophageal epithelium.
    Hamilton M; Mars Z; Sedeuil M; Rolland M; Jean D; Boudreau F; Giroux V
    Biol Open; 2024 Jan; 13(1):. PubMed ID: 38252116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of c-MYC gene expression in hematological malignancies.
    Okafor IM; Okoroiwu HU; Ogar CO
    Afr Health Sci; 2023 Jun; 23(2):265-273. PubMed ID: 38223598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcript CD81-215 may be a long noncoding RNA of stromal origin with tumor-promoting role in colon cancer.
    Jovanovic E; Babic T; Dragicevic S; Kmezic S; Nikolic A
    Cell Biochem Funct; 2023 Dec; 41(8):1503-1513. PubMed ID: 38014564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASCL1 and ASCL2 Define Distinct States of Neuroendocrine Prostate Cancer.
    Cancer Discov; 2023 Dec; ():OF1. PubMed ID: 38064349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascl2-Dependent Cell Dedifferentiation Drives Regeneration of Ablated Intestinal Stem Cells.
    Murata K; Jadhav U; Madha S; van Es J; Dean J; Cavazza A; Wucherpfennig K; Michor F; Clevers H; Shivdasani RA
    Cell Stem Cell; 2020 Mar; 26(3):377-390.e6. PubMed ID: 32084390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAF-associated genes putatively representing distinct prognosis by in silico landscape of stromal components of colon cancer.
    Okuno K; Ikemura K; Okamoto R; Oki K; Watanabe A; Kuroda Y; Kidachi M; Fujino S; Nie Y; Higuchi T; Chuman M; Washio M; Sakuraya M; Niihara M; Kumagai K; Sangai T; Kumamoto Y; Naitoh T; Hiki N; Yamashita K
    PLoS One; 2024; 19(4):e0299827. PubMed ID: 38557819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer.
    Xiang M; Gao Y; Zhou Y; Wang M; Yao X
    BMC Cancer; 2023 Jun; 23(1):595. PubMed ID: 37370046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Less demand on stem cell marker-positive cancer cells may characterize metastasis of colon cancer.
    Kaida T; Fujiyama Y; Soeno T; Yokota M; Nakamoto S; Goto T; Watanabe A; Okuno K; Nie Y; Fujino S; Yokota K; Harada H; Tanaka Y; Tanaka T; Yokoi K; Kojo K; Miura H; Yamanashi T; Sato T; Sasaki J; Sangai T; Hiki N; Kumamoto Y; Naitoh T; Yamashita K
    PLoS One; 2023; 18(4):e0277395. PubMed ID: 37098074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of early-onset colorectal cancer.
    Marx O; Mankarious M; Yochum G
    World J Biol Chem; 2023 Mar; 14(2):13-27. PubMed ID: 37034132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.